Tuberculosis: Promising new tuberculosis drug pretomanid approved, but will it be affordable?
GENEVA/NEW YORK – Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the approval by the US Food and Drug Administration (FDA) of a combination regimen containing a new drug, pretomanid, for the treatment of extensively drug-resistant tuberculosis (XDR-TB). As the third new drug developed for TB in over half a century, and the first to be … Read more